» Articles » PMID: 33413093

Cardiovascular Risk Factors and Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-analysis of 45 Studies and 18,300 Patients

Overview
Publisher Biomed Central
Date 2021 Jan 8
PMID 33413093
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A high prevalence of cardiovascular risk factors including age, male sex, hypertension, diabetes, and tobacco use, has been reported in patients with Coronavirus disease 2019 (COVID-19) who experienced adverse outcome. The aim of this study was to investigate the relationship between cardiovascular risk factors and in-hospital mortality in patients with COVID-19.

Methods: MEDLINE, Cochrane, Web of Sciences, and SCOPUS were searched for retrospective or prospective observational studies reporting data on cardiovascular risk factors and in-hospital mortality in patients with COVID-19. Univariable and multivariable age-adjusted analyses were conducted to evaluate the association between cardiovascular risk factors and the occurrence of in-hospital death.

Results: The analysis included 45 studies enrolling 18,300 patients. The pooled estimate of in-hospital mortality was 12% (95% CI 9-15%). The univariable meta-regression analysis showed a significant association between age (coefficient: 1.06; 95% CI 1.04-1.09; p < 0.001), diabetes (coefficient: 1.04; 95% CI 1.02-1.07; p < 0.001) and hypertension (coefficient: 1.01; 95% CI 1.01-1.03; p = 0.013) with in-hospital death. Male sex and smoking did not significantly affect mortality. At multivariable age-adjusted meta-regression analysis, diabetes was significantly associated with in-hospital mortality (coefficient: 1.02; 95% CI 1.01-1.05; p = 0.043); conversely, hypertension was no longer significant after adjustment for age (coefficient: 1.00; 95% CI 0.99-1.01; p = 0.820). A significant association between age and in-hospital mortality was confirmed in all multivariable models.

Conclusions: This meta-analysis suggests that older age and diabetes are associated with higher risk of in-hospital mortality in patients infected by SARS-CoV-2. Conversely, male sex, hypertension, and smoking did not independently correlate with fatal outcome.

Citing Articles

Triglycerides/High-Density Lipoprotein Ratio and Coronary Artery Disease: Results from a Large Single-Center Study.

De Luca G, Nardin M, Micari A, Kedhi E, Galasso G, Verdoia M J Clin Med. 2025; 14(4).

PMID: 40004901 PMC: 11856620. DOI: 10.3390/jcm14041371.


Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study.

Zahornacky O, Porubcin S, Rovnakova A, Jarcuska P, Semenovova D, Kubalcova P Cent Eur J Public Health. 2025; 32(Supplement):104-110.

PMID: 39832155 DOI: 10.21101/cejph.a8398.


Associations between pre-existing comorbidities and in-hospital cardiovascular events and mortality among COVID-19 patients in Bangladesh: a secondary analysis of a prospective cohort study.

Islam F, Salahin K, Chowdhury A, Amin M, Rahim A, Akter S BMJ Open. 2024; 14(8):e083982.

PMID: 39645266 PMC: 11367314. DOI: 10.1136/bmjopen-2024-083982.


Sociodemographic, Clinical, and Ventilatory Factors Influencing COVID-19 Mortality in the ICU of a Hospital in Colombia.

Perlaza C, Cruz Mosquera F, Moreno Reyes S, Tovar Salazar S, Cruz Rojas A, Espana Serna J Healthcare (Basel). 2024; 12(22).

PMID: 39595491 PMC: 11593780. DOI: 10.3390/healthcare12222294.


Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.

Wiedemann M, Speed V, Cunningham C, Higgins R, Curtis H, Andrews C Open Heart. 2024; 11(2).

PMID: 39214534 PMC: 11664366. DOI: 10.1136/openhrt-2024-002732.


References
1.
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang H . Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020; 81(1):e6-e12. PMC: 7195072. DOI: 10.1016/j.jinf.2020.04.002. View

2.
Mizumoto K, Chowell G . Estimating Risk for Death from Coronavirus Disease, China, January-February 2020. Emerg Infect Dis. 2020; 26(6):1251-1256. PMC: 7258458. DOI: 10.3201/eid2606.200233. View

3.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

4.
Ji Y, Ma Z, Peppelenbosch M, Pan Q . Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020; 8(4):e480. PMC: 7128131. DOI: 10.1016/S2214-109X(20)30068-1. View

5.
Jin X, Lian J, Hu J, Gao J, Zheng L, Zhang Y . Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69(6):1002-1009. PMC: 7133387. DOI: 10.1136/gutjnl-2020-320926. View